Business Description
Isofol Medical AB
ISIN : SE0009581051
Total Employee Number:
6Compare
Compare
Traded in other countries / regions
ISOFOL.Sweden5IU.Germany IPO Date
2017-04-04Description
Isofol Medical AB is a pharmaceutical company. It is a manufacturer of folate-based therapies. The company's drug candidate Modufolin enhances the effect of the current chemotherapy treatment for patients treated for colorectal cancer. Its products are used to increase efficacy and reduce the side effects of antimetabolite cancer treatment.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.82 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 34.1 | |||||
3-Year EPS without NRI Growth Rate | 34.5 | |||||
3-Year FCF Growth Rate | 38.9 | |||||
3-Year Book Growth Rate | -23.6 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 93.91 | |||||
9-Day RSI | 83.71 | |||||
14-Day RSI | 74.92 | |||||
3-1 Month Momentum % | 8.47 | |||||
6-1 Month Momentum % | -2.14 | |||||
12-1 Month Momentum % | -14.52 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 5.57 | |||||
Quick Ratio | 5.57 | |||||
Cash Ratio | 5.41 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -15.2 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -63.84 | |||||
ROA % | -51.55 | |||||
ROIC % | -320.33 | |||||
3-Year ROIIC % | -452.91 | |||||
ROCE % | -63.39 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 1.49 | |||||
PB Ratio | 2.32 | |||||
Price-to-Tangible-Book | 2.45 | |||||
EV-to-EBIT | -2.68 | |||||
EV-to-EBITDA | -2.68 | |||||
EV-to-Forward-Revenue | 11.12 | |||||
EV-to-FCF | -2.08 | |||||
| Price-to-Net-Current-Asset-Value | 2.45 | |||||
| Price-to-Net-Cash | 2.53 | |||||
Earnings Yield (Greenblatt) % | -37.42 | |||||
FCF Yield % | -21.41 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Isofol Medical AB Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | |||
| EPS (TTM) (kr) | -0.24 | ||
| Beta | -0.3053 | ||
| 3-Year Sharpe Ratio | 0.45 | ||
| 3-Year Sortino Ratio | 2.19 | ||
| Volatility % | 26.36 | ||
| 14-Day RSI | 74.92 | ||
| 14-Day ATR (kr) | 0.032452 | ||
| 20-Day SMA (kr) | 0.71195 | ||
| 12-1 Month Momentum % | -14.52 | ||
| 52-Week Range (kr) | 0.5515 - 1.18 | ||
| Shares Outstanding (Mil) | 320.49 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Isofol Medical AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Isofol Medical AB Stock Events
| Event | Date | Price (kr) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-12 | In 131 days | ||
| Third quarter earnings results for 2026 | 2026-11-12 | In 131 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-25 | In 52 days | ||
| Second quarter earnings results for 2026 | 2026-08-25 | In 52 days | ||
| General meeting for 2026 | 2026-05-19 15:00 | 0.76 (+8.84%) | ||
| First quarter earnings conference call for 2026 | 2026-05-19 | 0.76 (+8.84%) | ||
| First quarter earnings results for 2026 | 2026-05-19 | 0.76 (+8.84%) | ||
| Annual report for 2025 | 2026-04-10 | 0.70 (+6.22%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-18 | 0.61 (+4.74%) | ||
| Third quarter earnings conference call for 2025 | 2025-11-13 17:00 | 0.69 (-1.08%) |
Show
Entries
Isofol Medical AB Frequently Asked Questions
What is Isofol Medical AB(OSTO:ISOFOL)'s stock price today?
The current price of OSTO:ISOFOL is kr0.81. The 52 week high of OSTO:ISOFOL is kr1.18 and 52 week low is kr0.55.
When is next earnings date of Isofol Medical AB(OSTO:ISOFOL)?
The next earnings date of Isofol Medical AB(OSTO:ISOFOL) is 2026-08-25.
Does Isofol Medical AB(OSTO:ISOFOL) pay dividends? If so, how much?
Isofol Medical AB(OSTO:ISOFOL) does not pay dividend.
Press Release
Articles on Isofol Medical AB
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers